Madhav V Dhodapkar

Madhav V Dhodapkar

UNVERIFIED PROFILE

Are you Madhav V Dhodapkar?   Register this Author

Register author
Madhav V Dhodapkar

Madhav V Dhodapkar

Publications by authors named "Madhav V Dhodapkar"

Are you Madhav V Dhodapkar?   Register this Author

96Publications

2462Reads

11Profile Views

SOHO State of the Art Updates and Next Questions: T-Cell-Directed Immune Therapies for Multiple Myeloma: Chimeric Antigen Receptor-Modified T Cells and Bispecific T-Cell-Engaging Agents.

Clin Lymphoma Myeloma Leuk 2019 Sep 7;19(9):537-544. Epub 2019 Aug 7.

Tisch Cancer Institute, Icahn School of Medicine at Mt Sinai, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650193125
Publisher Site
http://dx.doi.org/10.1016/j.clml.2019.08.002DOI Listing
September 2019

Daratumumab in multiple myeloma.

Cancer 2019 Jul 5;125(14):2364-2382. Epub 2019 Apr 5.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32065DOI Listing
July 2019

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis.

Nat Commun 2019 04 23;10(1):1911. Epub 2019 Apr 23.

Department of Hematology and Medical Oncology, Emory University School of Medicine, 1365 Clifton Rd. NE, Atlanta, GA, 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-09555-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478743PMC
April 2019

Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.

Cancer 2019 Feb 17;125(3):416-423. Epub 2018 Oct 17.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31718
Publisher Site
http://dx.doi.org/10.1002/cncr.31718DOI Listing
February 2019

Navigating the Fas lane to improved cellular therapy for cancer.

J Clin Invest 2019 02 25;129(4):1522-1523. Epub 2019 Feb 25.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI127581DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436865PMC
February 2019

Checkpoint Inhibition in Myeloma: Opportunities and Challenges.

Front Immunol 2018 26;9:2204. Epub 2018 Sep 26.

Winship Cancer Institute, Emory University, Atlanta, GA, United States.

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fimmu.2018.02204
Publisher Site
http://dx.doi.org/10.3389/fimmu.2018.02204DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168958PMC
September 2018

MGUS, lymphoplasmacytic malignancies, and Gaucher disease: the significance of the clinical association.

Blood 2018 05 12;131(22):2500-2501. Epub 2018 Apr 12.

Section of Hematology, Department of Medicine, Yale Cancer Center, Yale University School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2018-02
Publisher Site
http://dx.doi.org/10.1182/blood-2018-02-834689DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981170PMC
May 2018

Hematologic Malignancies: Plasma Cell Disorders.

Am Soc Clin Oncol Educ Book 2017 ;37:561-568

From Yale University, New Haven, CT; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175546DOI Listing
December 2017

Natural Killer T Cells in Cancer Immunotherapy.

Front Immunol 2017 22;8:1178. Epub 2017 Sep 22.

Yale University, New Haven, CT, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2017.01178DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614937PMC
September 2017

Type II NKT Cells and Their Emerging Role in Health and Disease.

J Immunol 2017 02;198(3):1015-1021

Department of Medicine, University of California, San Diego, La Jolla, CA 92037

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1601399DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300729PMC
February 2017

MGUS to myeloma: a mysterious gammopathy of underexplored significance.

Blood 2016 12 13;128(23):2599-2606. Epub 2016 Oct 13.

Yale University, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-09-692954DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146746PMC
December 2016

Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma.

N Engl J Med 2016 Feb;374(6):555-61

From the Department of Medicine, Section of Hematology (S.N., A.R.B., C.S.B., M.V.D.), Section of Digestive Diseases (J.L., P.K.M.), Yale Liver Center (P.K.M.), and Yale Cancer Center (M.V.D.), Yale University School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1508808DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804194PMC
February 2016

Stem-Cell Transplantation for Amyloidosis: Improving Outcomes but Not for the Faint of Heart.

J Clin Oncol 2015 Nov 14;33(32):3689-90. Epub 2015 Sep 14.

Yale Cancer Center, Yale University, New Haven, CT

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.2224DOI Listing
November 2015

Immune Modulation in Hematologic Malignancies.

Semin Oncol 2015 Aug 3;42(4):617-25. Epub 2015 Jun 3.

Pediatrics (Hematology-Oncology); Yale Cancer Center, Yale University, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2015.05.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555986PMC
August 2015

Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo.

J Immunol 2015 Feb 24;194(3):950-9. Epub 2014 Dec 24.

Department of Medicine, Yale University School of Medicine, New Haven, CT 06520; Smilow Cancer Center, Yale University School of Medicine, New Haven, CT 06520; Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1401686DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380504PMC
February 2015

Classification of current anticancer immunotherapies.

Oncotarget 2014 Dec;5(24):12472-508

Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France. Pôle de Biologie, Hôpital Européen Georges Pompidou (HEGP), AP-HP, Paris, France.

View Article

Download full-text PDF

Source
https://lirias.kuleuven.be/bitstream/123456789/502976/1/2998
Web Search
http://oncotarget.com/abstract/2998
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350348PMC
http://dx.doi.org/10.18632/oncotarget.2998DOI Listing
December 2014

Targeting human dendritic cells in situ to improve vaccines.

Immunol Lett 2014 Nov 27;162(1 Pt A):59-67. Epub 2014 Jul 27.

Department of Medicine, Yale University, New Haven, CT, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imlet.2014.07.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506641PMC
November 2014

Trial watch: Dendritic cell-based anticancer therapy.

Oncoimmunology 2014 Nov 21;3(11):e963424. Epub 2014 Dec 21.

Gustave Roussy Cancer Campus ; Villejuif, France ; INSERM , U1138; Paris France ; Equipe 11 labellisée par la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers ; Paris France ; Université Paris Descartes/Paris V; Sorbonne Paris Cité ; Paris France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/21624011.2014.963424DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292311PMC
November 2014

Nanoparticle-mediated combinatorial targeting of multiple human dendritic cell (DC) subsets leads to enhanced T cell activation via IL-15-dependent DC crosstalk.

J Immunol 2014 Sep 30;193(5):2297-305. Epub 2014 Jul 30.

Department of Pediatrics, Yale School of Medicine, Yale University, New Haven, CT 06510; Yale Cancer Center, Yale School of Medicine, Yale University, New Haven, CT 06510

View Article

Download full-text PDF

Source
http://www.jimmunol.org/lookup/doi/10.4049/jimmunol.1400489
Publisher Site
http://dx.doi.org/10.4049/jimmunol.1400489DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195217PMC
September 2014

Recent advances and new opportunities for targeting human dendritic cells in situ.

Oncoimmunology 2014;3(8):e954832. Epub 2014 Aug 3.

Yale University ; New Haven, CT USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/21624011.2014.954832DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292727PMC
August 2014

SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer.

Oncoimmunology 2013 Jul 10;2(7):e25205. Epub 2013 Jun 10.

Department of Pediatrics; Yale University; New Haven, CT USA ; Yale Cancer Center; Yale University; New Haven, CT USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/onci.25205
Publisher Site
http://dx.doi.org/10.4161/onci.25205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782159PMC
July 2013

Personalized immune-interception of cancer and the battle of two adaptive systems--when is the time right?

Cancer Prev Res (Phila) 2013 Mar 22;6(3):173-6. Epub 2013 Jan 22.

Yale University School of Medicine, 333 Cedar Street, Box 208028, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
http://cancerpreventionresearch.aacrjournals.org/cgi/doi/10.
Publisher Site
http://dx.doi.org/10.1158/1940-6207.CAPR-13-0011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593788PMC
March 2013

Vaccines targeting cancer stem cells: are they within reach?

Cancer J 2011 Sep-Oct;17(5):397-402

Departments of Medicine, Immunobiology and Pediatrics, Yale University, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e318233e730DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224821PMC
March 2012

Adipokines in MM: time to trim the fat.

Blood 2011 Nov;118(22):5716-7

Yale University, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2011-10-37
Publisher Site
http://dx.doi.org/10.1182/blood-2011-10-379834DOI Listing
November 2011

Harnessing natural killer T (NKT) cells in human myeloma: progress and challenges.

Clin Immunol 2011 Aug 12;140(2):160-6. Epub 2011 Jan 12.

Section of Hematology, Yale University, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2010.12.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224820PMC
August 2011

Spontaneous and therapy-induced immunity to pluripotency genes in humans: clinical implications, opportunities and challenges.

Cancer Immunol Immunother 2011 Mar 23;60(3):413-8. Epub 2010 Nov 23.

Section of Hematology, Yale University, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-010-0944-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574640PMC
March 2011

Protein stress? pDCs go Toll-free.

Blood 2011 Jan;117(2):376-7

Yale University, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-11-315838DOI Listing
January 2011

Natural immunity to pluripotency antigen OCT4 in humans.

Proc Natl Acad Sci U S A 2010 May 19;107(19):8718-23. Epub 2010 Apr 19.

Department of Pediatrics, Yale University, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0915086107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889362PMC
May 2010

Immunity to stemness genes in human cancer.

Curr Opin Immunol 2010 Apr 9;22(2):245-50. Epub 2010 Feb 9.

Section of Hematology, Yale University, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09527915100001
Publisher Site
http://dx.doi.org/10.1016/j.coi.2010.01.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892711PMC
April 2010

Waldenstrom's macroglobulinemia: Recent advances in biology and therapy.

Clin Adv Hematol Oncol 2009 Oct;7(10):677-81, 687-90

Yale University, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612541PMC
October 2009

Harnessing CD1d-restricted T cells toward antitumor immunity in humans.

Ann N Y Acad Sci 2009 Sep;1174:61-7

Section of Hematology, Yale University, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2009.04931.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782771PMC
September 2009

Role of teichoic acid choline moieties in the virulence of Streptococcus pneumoniae.

Infect Immun 2009 Jul 11;77(7):2824-31. Epub 2009 May 11.

Laboratory of Microbiology, The Rockefeller University, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/IAI.00986-08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708541PMC
July 2009

NKT cells in p53 deficiency.

Blood 2009 Jun;113(25):6268-9

Yale University.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2009-03-21
Publisher Site
http://dx.doi.org/10.1182/blood-2009-03-211318DOI Listing
June 2009

Monoclonal antibodies for cancer immunotherapy.

Lancet 2009 Mar;373(9668):1033-40

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(09)60251-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677705PMC
March 2009

Harnessing human CD1d restricted T cells for tumor immunity: progress and challenges.

Front Biosci (Landmark Ed) 2009 Jan 1;14:796-807. Epub 2009 Jan 1.

Hematology Section, Yale University School of Medicine, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762346PMC
http://dx.doi.org/10.2741/3278DOI Listing
January 2009

Role of chaperones and FcgammaR in immunogenic death.

Curr Opin Immunol 2008 Oct 21;20(5):512-7. Epub 2008 Jun 21.

Section of Hematology, Yale University, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2008.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224819PMC
October 2008

Does lenalidomide plus dexamethasone improve outcome in patients with relapsed multiple myeloma?

Nat Clin Pract Oncol 2008 Jul 13;5(7):372-3. Epub 2008 May 13.

Department of Hematology and Director of Hematologic Malignancies Yale Cancer Center, CT 06520, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ncponc1138
Publisher Site
http://dx.doi.org/10.1038/ncponc1138DOI Listing
July 2008

Towards a better way to die with chemotherapy: role of heat shock protein exposure on dying tumor cells.

Cell Cycle 2007 Aug 18;6(16):1962-5. Epub 2007 Jun 18.

Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.6.16.4601DOI Listing
August 2007

Enhancement of clonogenicity of human multiple myeloma by dendritic cells.

J Exp Med 2006 Aug 31;203(8):1859-65. Epub 2006 Jul 31.

Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20052136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034506PMC
August 2006

Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications.

Blood 2006 Jul 28;108(2):618-21. Epub 2006 Mar 28.

Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-10-4184DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895497PMC
July 2006

Immunoprevention of cancer.

Hematol Oncol Clin North Am 2006 Jun;20(3):735-50

Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S088985880600045
Publisher Site
http://dx.doi.org/10.1016/j.hoc.2006.02.009DOI Listing
June 2006

Immune response to premalignancy: insights from patients with monoclonal gammopathy.

Ann N Y Acad Sci 2005 Dec;1062:22-8

Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1358.004DOI Listing
December 2005

Harnessing host immune responses to preneoplasia: promise and challenges.

Cancer Immunol Immunother 2005 May 16;54(5):409-13. Epub 2004 Dec 16.

Laboratory of Tumor Immunology and Immunotherapy, Rockefeller University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-004-0607-8DOI Listing
May 2005

Recruiting dendritic cells to improve antibody therapy of cancer.

Proc Natl Acad Sci U S A 2005 May 25;102(18):6243-4. Epub 2005 Apr 25.

Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0502547102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1088395PMC
May 2005

Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628.

Blood 2004 Dec 12;104(12):3520-6. Epub 2004 Aug 12.

Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University and Hematology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2004-05-19
Publisher Site
http://dx.doi.org/10.1182/blood-2004-05-1924DOI Listing
December 2004

Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy.

J Exp Med 2003 Dec 24;198(11):1753-7. Epub 2003 Nov 24.

Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20031030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194131PMC
December 2003

Severe and selective deficiency of interferon-gamma-producing invariant natural killer T cells in patients with myelodysplastic syndromes.

Br J Haematol 2003 Aug;122(4):617-22

Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2003.04465.xDOI Listing
August 2003

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma.

J Exp Med 2003 Jun 9;197(12):1667-76. Epub 2003 Jun 9.

Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20021650DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193955PMC
June 2003

Dendritic cells and immunotherapy for cancer.

Int J Hematol 2003 Jun;77(5):439-43

Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
June 2003

Dendritic cell-mediated immunization in macroglobulinemia.

Semin Oncol 2003 Apr;30(2):305-8

Laboratory of Tumor Immunology and Immunotherapy, Rockefeller University, and Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009377540370099
Publisher Site
http://dx.doi.org/10.1053/sonc.2003.50058DOI Listing
April 2003

Detection and activation of human Valpha24+ natural killer T cells using alpha-galactosyl ceramide-pulsed dendritic cells.

J Immunol Methods 2003 Jan;272(1-2):147-59

Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0022-1759(02)00497-0DOI Listing
January 2003

T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells.

Proc Natl Acad Sci U S A 2002 Oct 16;99(20):13009-13. Epub 2002 Sep 16.

Laboratory of Tumor Immunology and Immunotherapy, The Rockefeller University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.202491499DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC130577PMC
October 2002

Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans.

Blood 2002 Jul;100(1):174-7

Laboratory of Tumor Immunology and Immunotherapy Rockefeller University; New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.v100.1.174DOI Listing
July 2002